Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mae O Gordon

Showing results (61-70 of 104) with videos related to

Pageof 11
Sort By:
Investigative Ophthalmology & Visual Science|March 8, 2012
Effect of treatment on the rate of visual field change in the ocular hypertension treatment study observation groupCarlos Gustavo De Moraes, Shaban Demirel, Stuart K Gardiner, et al.
Investigative Ophthalmology & Visual Science|December 14, 2011
The rate of visual field change in the ocular hypertension treatment studyShaban Demirel, Carlos Gustavo V De Moraes, Stuart K Gardiner, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|December 15, 2010
Longitudinal and cross-sectional analyses of visual field progression in participants of the Ocular Hypertension Treatment StudyPaul H Artes, Balwantray C Chauhan, John L Keltner, et al.
American Journal of Ophthalmology|October 24, 2006
Topical ocular hypotensive medication and lens opacification: evidence from the ocular hypertension treatment studyDavid C Herman, Mae O Gordon, Julia A Beiser, et al.
JAMA Ophthalmology|November 15, 2019
Accuracy of Kalman Filtering in Forecasting Visual Field and Intraocular Pressure Trajectory in Patients With Ocular HypertensionGian-Gabriel P Garcia, Mariel S Lavieri, Chris Andrews, et al.
Ophthalmology|March 5, 2002
Baseline visual field characteristics in the ocular hypertension treatment studyChris A Johnson, John L Keltner, Kimberly E Cello, et al.
Journal of Child Neurology|December 7, 2013
Reproducibility of detecting silent cerebral infarcts in pediatric sickle cell anemiaRobert I Liem, Jingxia Liu, Mae O Gordon, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|June 7, 2002
The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucomaMichael A Kass, Dale K Heuer, Eve J Higginbotham, et al.
Ophthalmology|November 11, 2006
Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension, , Mae O Gordon, et al.
American Journal of Ophthalmology|May 22, 2026
Ocular Hypertension Treatment Study: Effect of time after incident glaucoma on OCT optic nerve head and macula measurementsEvan Walker, Christopher Bowd, Sonia Jain, et al.
Pageof 11

Showing results (61-70 of 104) with videos related to

Sort By:
Pageof 11
Investigative Ophthalmology & Visual Science|March 8, 2012
Effect of treatment on the rate of visual field change in the ocular hypertension treatment study observation groupCarlos Gustavo De Moraes, Shaban Demirel, Stuart K Gardiner, et al.
Investigative Ophthalmology & Visual Science|December 14, 2011
The rate of visual field change in the ocular hypertension treatment studyShaban Demirel, Carlos Gustavo V De Moraes, Stuart K Gardiner, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|December 15, 2010
Longitudinal and cross-sectional analyses of visual field progression in participants of the Ocular Hypertension Treatment StudyPaul H Artes, Balwantray C Chauhan, John L Keltner, et al.
American Journal of Ophthalmology|October 24, 2006
Topical ocular hypotensive medication and lens opacification: evidence from the ocular hypertension treatment studyDavid C Herman, Mae O Gordon, Julia A Beiser, et al.
JAMA Ophthalmology|November 15, 2019
Accuracy of Kalman Filtering in Forecasting Visual Field and Intraocular Pressure Trajectory in Patients With Ocular HypertensionGian-Gabriel P Garcia, Mariel S Lavieri, Chris Andrews, et al.
Ophthalmology|March 5, 2002
Baseline visual field characteristics in the ocular hypertension treatment studyChris A Johnson, John L Keltner, Kimberly E Cello, et al.
Journal of Child Neurology|December 7, 2013
Reproducibility of detecting silent cerebral infarcts in pediatric sickle cell anemiaRobert I Liem, Jingxia Liu, Mae O Gordon, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|June 7, 2002
The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucomaMichael A Kass, Dale K Heuer, Eve J Higginbotham, et al.
Ophthalmology|November 11, 2006
Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension, , Mae O Gordon, et al.
American Journal of Ophthalmology|May 22, 2026
Ocular Hypertension Treatment Study: Effect of time after incident glaucoma on OCT optic nerve head and macula measurementsEvan Walker, Christopher Bowd, Sonia Jain, et al.
Pageof 11